ALE (ALE) Stock News

Parsons Corporation reported a $70 million year-over-year decrease in net income and a 72% decline in adjusted EBITDA for Q2 2026, attributed to portfolio-shaping actions and a joint venture program charge. The disappointing results led to a stock price drop and prompted a securities law compliance investigation by Holzer & Holzer, LLC.

The FDA announced that Capricor Therapeutics' stem cell treatment for Duchenne muscular dystrophy did not meet the objectives of its Phase 3 trial, contradicting the company's claims from the previous year. Following this disclosure, Capricor's stock price declined significantly.

Shareholder class action lawsuits have been filed against Hertz Global Holdings, BitGo Holdings, and Wix.com Ltd., alleging false and misleading statements regarding their business operations and financial conditions. Hertz faces allegations of deteriorating liquidity and misrepresentation of used-car market conditions. Investors who suffered losses during the specified periods are encouraged to contact the law firm.

A shareholder class action lawsuit has been filed against BitGo Holdings, Inc., alleging that the company's IPO offering documents were negligently prepared and contained false or misleading statements. The lawsuit claims BitGo understated risks related to declining digital asset prices and lacked a reasonable basis for statements about financial performance. The deadline to apply as lead plaintiff is August 7, 2026.

Shareholder class action lawsuits have been filed against Wix.com Ltd., Hertz Global Holdings, Inc., and BitGo Holdings, Inc. The Wix lawsuit alleges overstatement of AI product competitiveness and understatement of development costs. Investors who purchased shares during specified periods and experienced losses are encouraged to contact the law firm.

A shareholder class action lawsuit has been filed against PicS N.V. alleging the company made false and misleading statements in its January 2026 IPO offering documents. The allegations include undisclosed deficiencies in credit evaluation procedures, material reclassifications of credit exposures, unreported elevated Stage 3 formation rates, overstated credit models, and undisclosed deterioration in customer credit quality and heightened default risks. The lead plaintiff deadline is August 4, 2026.

A securities fraud lawsuit has been filed against GPGI, Inc. alleging the company misled investors about its acquisition of Husky Technologies Limited, overstating its value and earnings projections while downplaying management fees to Resolute Holdings. Following short seller allegations in February 2026 and disappointing Q4 2025 and Q1 2026 results, GPGI shares declined significantly, with the company cutting 2026 guidance substantially. Investors have until September 14, 2026 to request lead plaintiff appointment.

Pomerantz LLP is investigating Pentair plc for potential securities fraud following the company's July 14, 2026 announcement of significantly reduced Q2 2026 guidance and full-year 2026 outlook, primarily due to adverse Pool channel inventory conditions. The announcement also included the departure of CFO Nicholas Brazis, and Pentair's stock fell 15% to $64.33 per share on July 15, 2026.

Pomerantz LLP has filed a class action lawsuit against Hertz Global Holdings for alleged securities fraud. The lawsuit stems from Hertz's June 24, 2026 announcement of a $300 million capital raise and 37 million share offering, coupled with disclosure of unexpected losses in the used car market that would significantly reduce second-quarter earnings. The stock fell 40.71% on the news. Investors have until September 22, 2026 to join the class action.

Pomerantz LLP is investigating Alibaba Group Holding Limited for potential securities fraud following two major incidents: Anthropic's accusation that Alibaba obtained illicit access to its Claude AI model through fake accounts, and a $600 million non-prosecution agreement with the U.S. Department of Justice for failing to prevent illegal pharmaceutical sales on its platforms. These disclosures triggered significant stock price declines.

Pomerantz LLP is investigating potential securities fraud claims against VenHub Global, Inc. The investigation follows VenHub's disclosure of severe financial distress in its annual report, including only $864,450 in revenue for FY 2025, a $62.4 million net loss, stockholders' deficit of $10.3 million, and going concern doubts. The company's stock price fell sharply following these disclosures.

Pomerantz LLP is investigating potential securities fraud claims against Omeros Corporation following the company's announcement on June 26, 2026, that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a negative opinion on the marketing authorization application for narsoplimab for treating TA-TMA. The negative regulatory decision triggered a 19.12% stock price decline, falling $2.05 per share to $8.67.

Pomerantz LLP has filed a class action lawsuit against Microsoft Corporation alleging securities fraud. The lawsuit stems from Microsoft's January 2026 earnings announcement revealing slower-than-expected Azure growth due to capacity constraints diverted to AI/Copilot, massive capital expenditures of $37.5 billion in Q2, and disappointing Copilot adoption at only 15 million seats versus analyst expectations. Subsequent reports revealed functionality issues with Copilot products and market share losses to competitors like Google Gemini, leading to a stock price decline of nearly 10%. Investors have until August 11, 2026 to request Lead Plaintiff status.

Hagens Berman has filed a securities class action lawsuit against PicS N.V. alleging the company made materially false statements in its January 2026 IPO by failing to disclose internal findings of deficient credit evaluation procedures discovered in December 2025. The lawsuit claims these omissions masked severe portfolio deterioration and heightened default risks. Following post-IPO disclosures in March and June 2026, PicS stock plummeted over 50% from its $19.00 IPO price to under $9.00. The lead plaintiff deadline is August 4, 2026.

Hagens Berman is investigating Alignment Healthcare, Inc. (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to artificially inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

Law firm Kirby McInerney LLP is investigating ADTRAN Holdings for potential securities fraud following the company's announcement of preliminary Q2 2026 results that significantly missed guidance. ADTRAN reported revenue of $280-282 million and non-GAAP operating margin of 3.5-4.0%, falling short of prior guidance of $283-303 million revenue and 5-9% margin. The company attributed the miss to a project delay from a single customer and elevated component/freight costs. ADTRAN stock declined 14% on the news.

Kirby McInerney LLP has filed a securities fraud class action lawsuit against Insulet Corporation on behalf of investors who purchased securities between February 21, 2025 and May 26, 2026. The lawsuit alleges that Insulet failed to disclose defective manufacturing controls and safety risks. Two significant product corrections were announced in March and May 2026, resulting in substantial stock price declines of approximately 7% and 5% respectively. The deadline to request lead plaintiff appointment is August 31, 2026.

A class action lawsuit has been filed against PicS N.V. (PicPay) alleging that IPO offering documents contained false and misleading statements regarding credit evaluation procedures, loan quality, and undisclosed credit deterioration. The stock has declined over 50% from its $19 IPO price to below $9 per share. Investors have until August 4, 2026 to apply for lead plaintiff status.

A class action lawsuit has been filed against Hub Group, Inc. for allegedly making false and misleading statements regarding its financial statements from Q1 2023 through Q3 2025. The company allegedly made material misstatements concerning revenue recognition, operating income, and expense reporting due to premature transaction recognition and cost understatement. Investors who purchased shares between April 28, 2023, and May 11, 2026, may be eligible to participate in the lawsuit.

The FDA announced that Capricor Therapeutics' stem cell treatment for Duchenne muscular dystrophy did not meet the objectives of its Phase 3 trial, contradicting the company's claims from the previous year. Following this disclosure, Capricor's stock price declined significantly.

A securities class action lawsuit has been filed against PROCEPT BioRobotics Corporation on behalf of investors who purchased stock between February 28, 2024 and February 25, 2026. The lawsuit alleges the company made materially false and misleading statements regarding business operations, growth prospects, and financial stability, causing stock prices to trade at artificially inflated levels. Investors suffered significant losses when the truth was disclosed.

Shareholder class action lawsuits have been filed against Embecta Corp. and Via Transportation Inc., with allegations of false statements and failure to disclose segment weakness and revenue guidance disruptions. Additionally, Holzer & Holzer, LLC announced an investigation into ADTRAN Holdings Inc. regarding potential federal securities law violations. Investors who suffered losses during the relevant periods are encouraged to contact the law firm.

ADTRAN Holdings announced preliminary Q2 2026 results below guidance, citing a project delay from a single customer and elevated component and freight costs. The stock price declined following the announcement, prompting a securities investigation by Holzer & Holzer, LLC.

Holzer & Holzer, LLC has filed shareholder class action lawsuits against Via Transportation and Embecta Corp., alleging false and misleading statements in their IPO registration statements and securities disclosures. The firm is also investigating ADTRAN Holdings for potential federal securities law violations. Investors who suffered losses are encouraged to contact the firm.

Class action lawsuits have been filed against AeroVironment, Calix, Zoetis, and Lucid Group, alleging that company executives made materially false statements and failed to disclose material adverse facts about their businesses. The lawsuits cover various issues including understated competition, supply chain problems, declining product adoption, and manufacturing disruptions. Lead plaintiff deadlines range from July 27-28, 2026.

Law firm Robbins Geller Rudman & Dowd LLP announced class action lawsuits against Primoris Services Corporation for allegedly making false statements about cost estimation and project management in its renewable energy business. The lawsuit covers investors who purchased PRIM stock between August 5, 2025 and June 22, 2026. Primoris stock experienced significant declines following multiple negative disclosures about cost overruns and guidance reductions. The firm is seeking a lead plaintiff by September 21, 2026.

Law firm Robbins Geller has announced class action lawsuits against Intuit Inc. for allegedly making false statements about competitive advantages and TurboTax revenue growth, resulting in a 20% stock drop after weak Q3 results. The firm is also filing cases against EquipmentShare.com and PROCEPT BioRobotics for similar securities fraud allegations.

A securities fraud class action lawsuit has been filed against PicS N.V. (NASDAQ: PICS) alleging material misstatements and omissions in its January 30, 2026 IPO documents. The complaint claims PicS failed to disclose deficient credit evaluation procedures, a significant reclassification of credit exposures, elevated Stage 3 formation rates, and deteriorating customer credit quality. The stock has declined over 50% from its $19 IPO price to below $9 per share. Investors have until August 4, 2026, to seek lead plaintiff status.

A securities class action lawsuit has been filed against GRAIL, Inc. for allegedly providing misleading statements about its NHS-Galleri cancer screening trial. The lawsuit claims defendants concealed material adverse facts about the trial's ability to demonstrate a reduction in Stage III-IV cancers. Investors who purchased GRAIL stock between May 13, 2025 and February 19, 2026 may be eligible for compensation. The deadline to serve as lead plaintiff is August 4, 2026.

Hagens Berman has expanded a securities class action lawsuit against Roblox Corporation, covering investors who purchased stock between October 31, 2024 and April 30, 2026. The lawsuit alleges Roblox misled investors about its safety measures and failed to disclose the negative business impact of its age verification rollout, which caused a 16% stock decline in October 2025 and led to reduced user growth and slashed revenue guidance in April 2026.